Application of the IDSA Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients: Impact on Reducing the Use of Glycopeptides

Clicks: 176
ID: 113203
2015
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Application of the IDSA Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients: Impact on Reducing the Use of Glycopeptides - Volume 22 Issue 10 - Marcio Nucci, Marianne Landau, Fernanda Silveira, Nelson Spector, Wolmar Pulcheri
Reference Key
nucci2015infectionapplication Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Marcio Nucci;Marianne Landau;Fernanda Silveira;Nelson Spector;Wolmar Pulcheri;
Journal infection control & hospital epidemiology
Year 2015
DOI
doi:10.1086/501839
URL
http://dx.doi.org/10.1086/501839
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE Teaching humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't adult female male adolescent aged middle aged Child hospitals drug therapy fever / drug therapy* neutropenia / drug therapy* anti-bacterial agents / therapeutic use* combination / therapeutic use* fever / complications neutropenia / complications brazil vancomycin / therapeutic use practice guidelines as topic* cefepime cephalosporins / administration & dosage ceftazidime / therapeutic use pmid:11776354 doi:10.1086/501839 m nucci m landau w pulcheri amikacin / therapeutic use oxacillin / administration & dosage teicoplanin / therapeutic use

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.